Devazy (Azithromycin for oralsuspension USP)
Each 5mlreconstituted suspension contains
Azithromycin(as dihydrate) USP Eq. to Azithromycin (Anhydrous) 200 mg
For thetreatment of patients with mild to moderate infections caused by susceptiblestrains of the designated microorganisms in the specific conditions listedbelow:
â€¢ Acute Bacterial Exacerbations of ChronicObstructive Pulmonary Disease and Acute bacterial sinusitis: Due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumonia.
â€¢ Community-Acquired Pneumonia: Due to Chlamydia pneumoniae, Haemophilusinfluenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae in patients appropriate for oral therapy.
â€¢ Pharyngitis/Tonsillitis: Caused byStreptococcus pyogenesasan alternative to first-line therapy in individuals whocannot use first-line therapy.
â€¢ Uncomplicated Skin and Skin StructureInfections: Due to Staphylococcus aureus, Streptococcus pyogenes, orStreptococcus agalactiae.
â€¢ Urethritis and Cervicitis: Due to Chlamydiatrachomatis or Neisseria gonorrhoeae.
â€¢ Genital Ulcer Disease:In men due to Haemophilusducreyi(chancroid). Due to the small number of women included in clinicaltrials, the efficacy of azithromycin in the treatment of chancroid in women hasnot been established.
â€¢ Acute otitis media: due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcuspneumoniae.
â€¢ Community acquired pneumonia: due to Chlamydia pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae or Streptococcus pneumoniae in patients appropriate for oraltherapy.
â€¢ Pharyngitis/Tonsillitis: due to Streptococcus pyogenes as an alternative to first-line therapy inindividuals who cannot use first-line therapy.
C-912, Kailas Business Park, Park site, Vikhroli West, Mumbai, Maharashtra, 400079, India